Alec Machiels - Jan 14, 2022 Form 4 Insider Report for Apellis Pharmaceuticals, Inc. (APLS)

Role
Director
Signature
/s/ David Watson, attorney-in-fact for Alec Machiels
Stock symbol
APLS
Transactions as of
Jan 14, 2022
Transactions value $
-$47,363
Form type
4
Date filed
1/19/2022, 07:15 PM
Previous filing
Jan 4, 2022
Next filing
Feb 16, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction APLS Common Stock Options Exercise $3.34K +1.25K +0.19% $2.67* 675K Jan 14, 2022 Direct F1
transaction APLS Common Stock Sale -$50.7K -1.25K -0.19% $40.56 674K Jan 14, 2022 Direct F1
holding APLS Common Stock 1.95K Jan 14, 2022 See Footnote F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APLS Stock Option(Right to Buy) Options Exercise $0 -1.25K -4.38% $0.00 27.3K Jan 14, 2022 Common Stock 1.25K $2.67 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This is a scheduled exercise and sale from 10B5-1 trading plan.
F2 Owned by spouse.
F3 This option was granted on December 5, 2013 and fully vested.